The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke (EUREKA)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by Severance Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Severance Hospital
ClinicalTrials.gov Identifier:
NCT01364220
First received: May 26, 2011
Last updated: July 20, 2011
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)